Latest news
Dr. Jenny Kokai Contributes to ATHE Award-Winning Volume - University of South FloridaUniversity of South Florida · Thu, 06 Aug 2026 21:29:30 GMTAlterity CEO Set to Present at Canaccord Growth Conference - Stock TitanStock Titan · Thu, 06 Aug 2026 11:25:00 GMTAlterity Therapeutics (NASDAQ: ATHE) plans Canaccord Growth Conference talk - Stock TitanStock Titan · Thu, 06 Aug 2026 10:06:42 GMTATHE 6-K & SEC Filings - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 07:00:00 GMT[6-K] ALTERITY THERAPEUTICS LTD Current Report (Foreign Issuer) - Stock TitanStock Titan · Tue, 04 Aug 2026 10:04:51 GMTAlterity Therapeutics (ATHE) Gains 1.24% to $4.5, Holding Above Key Support - Elliott Wave Count - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 02:43:13 GMTAlterity Therapeutics (ATHE) Gains 1.24% to $4.5, Holding Above Key Support - Last Point Resistance - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 02:36:20 GMTAlterity’s ATH434 Trial for Rare MSA May Enroll 200 Patients - Stock TitanStock Titan · Thu, 30 Jul 2026 11:25:00 GMT